First approved by the FDA in 1998, Levaquin® is an antibiotic used to treat infections in the body’s organs and skin. In 2004, there was a recognized association between the active ingredient in Levaquin®, levofloxacin, and a type of nerve damage called peripheral neuropathy. This condition damages the body’s nerves and can result in numbness, weakness, and pain.
In 2013, the FDA strengthened the warnings associated with Levaquin®. This involved the risk of nerve damage and tendon rupture. The warnings came after a number of adverse event reports were reviewed by the administration. The reports showed the connection between Levaquin® and the development of peripheral neuropathy as a sudden and permanent possibility. It was determined that this risk was not adequately shown on the labeling of the drug.
As more and more individuals are becoming aware of the associated risks of Levaquin® and the possibility of permanent nerve damage, lawsuits are beginning to mount. At Bailey Cowan Heckaman PLLC, our Levaquin® injury attorneys are dedicated to holding the manufacturer accountable for not providing adequate warnings of the dangers involved with the drug.
We are investigating potential claims against the makers of Levaquin® to determine what can be done and what legal action may be available to patients. When companies fail to adequately test their prescription drugs or fail to provide warning regarding the potential dangers, they are acting negligently. This can result in a product liability claim or class action lawsuit.
If you or someone you love is taking Levaquin® and nerve damage has developed, call us today. Permanent nerve damage can alter a person’s life forever, limiting their ability to work and increasing their hospital bills. We are ready to represent you and help you seek the compensation you need to recover from your damages. Let us help you today.